Is Avalyn Pharma Inc. Common Stock (AVLN) a Buy, Sell, or Hold?
NASDAQ : AVLN
Avalyn Pharma Inc. Common Stock — Earnings Estimates
$29.26 USD
$0.23 (0.79%)
- Volume
- 125.56K
- Average Volume
- 519.64K
- Market Capitalization
- $1.3B
- P/E Ratio
- -14.34
- Dividend Yield
- 0.00%
- Price Target
- $52.50
- Year High
- $33.32
- Year Low
- $24.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.19
Annual earnings financials
AVLN financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
AVLN Estimated and Actual Revenue by Quarter
AVLN Estimated and Actual EPS by Quarter
AVLN Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 0 | - | - | - | - | - | - |
| 2026-09-30 | 0 | - | - | - | - | - | - |
| 2026-06-30 | 0 | - | - | - | - | - | - |
| 2026-03-31 | 0 | - | - | - | - | - | - |
AVLN Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2026-12-31 | 0 | -24.25M | -24.25M | -24.25M | - | - | - |
| 2026-09-30 | 0 | -24.25M | -24.25M | -24.25M | - | - | - |
| 2026-06-30 | 0 | -30.8M | -30.8M | -30.8M | - | - | - |
| 2026-03-31 | 0 | -249.9M | -249.9M | -249.9M | - | - | - |
AVLN Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2026-12-31 | 0 | - | - | - | 1 | -0.58 | -0.58 | -0.58 |
| 2026-09-30 | 0 | - | - | - | 1 | -0.58 | -0.58 | -0.58 |
| 2026-06-30 | 0 | - | - | - | 1 | -0.73667 | -0.73667 | -0.73667 |
| 2026-03-31 | 0 | - | - | - | 1 | -5.97667 | -5.97667 | -5.97667 |